Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis’s Gilenya to Take 13% of Market in Year, Leerink Says
Novartis’s Gilenya to Take 13% of Market in Year, Leerink Says
Novartis’s Gilenya to Take 13% of Market in Year, Leerink Says
Submitted by
admin
on November 10, 2010 - 11:02am
Source:
Bloomberg
News Tags:
Novartis
Gilenya
MS
multiple sclerosis
Headline:
Novartis’s Gilenya to Take 13% of Market in Year, Leerink Says
Do Not Allow Advertisers to Use My Personal information
